Filtered By:
Drug: Aspirin
Procedure: Coronary Angioplasty
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 338 results found since Jan 2013.
Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study
CONCLUSIONS: As compared with ticagrelor plus aspirin, ticagrelor monotherapy after a short DAPT duration lowered bleeding complications without increasing the ischemic risk, irrespective of DES type. We observed no significant differences among DES-types.PMID:34881696 | DOI:10.4244/EIJ-D-21-00721
Source: EuroIntervention - December 9, 2021 Category: Cardiovascular & Thoracic Surgery Authors: George Dangas Usman Baber Samin K Sharma Gennaro Giustino Samantha Sartori Johny Nicolas Ridhima Goel Shamir R Mehta David J Cohen Dominick J Angiolillo Zhongjie Zhang Anton Camaj Davide Cao Carlo Briguori Dariusz Dudek Javier Escaned Kurt Huber Timothy C Source Type: research
Aspirin in the Modern Era of Cardiovascular Disease Prevention
Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):36-47. doi: 10.14797/mdcvj.293. eCollection 2021.ABSTRACTAspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its traditional use as a core therapy for secondary prevention of CVD is well recognized. However, with the advent of newer antiplatelet agents and an increasing understanding of aspirin's bleeding risks, its role across the full spectrum of modern CVD prevention has become less certain. As a consequence, recent trials have begun investigating aspirin-free strategies in secondary prevention. For exampl...
Source: Methodist DeBakey Cardiovascular Journal - November 26, 2021 Category: Cardiology Authors: Ella Murphy James M G Curneen John W McEvoy Source Type: research
